US Stock MarketDetailed Quotes
FLR Fluor
- 48.430
- -0.770-1.57%
Close Aug 16 16:00 ET
- 48.430
- 0.0000.00%
Post 20:01 ET
8.30BMarket Cap20.88P/E (TTM)
49.000High48.100Low1.55MVolume49.000Open49.200Pre Close75.08MTurnover0.91%Turnover Ratio89.69P/E (Static)171.29MShares51.64052wk High3.87P/B8.20BFloat Cap32.31052wk Low--Dividend TTM169.27MShs Float84.909Historical High--Div YieldTTM1.83%Amplitude2.850Historical Low48.574Avg Price1Lot Size
Fluor Stock Forum
Sign in to post a comment
On Saturday, Donald Trump was shot at a campaign rally in Pennsylvania, which could be a key moment that completely disrupts the US election landscape this year. Following the incident, data from Polymarket shows that Trump's chances of winning the election have skyrocketed to 71%.
After shooting, Bitcoin price briefly surpassed $63,000. $Trump Media & Technology (DJT.US)$ surged over 70% in Mond...
After shooting, Bitcoin price briefly surpassed $63,000. $Trump Media & Technology (DJT.US)$ surged over 70% in Mond...
130
25
Insiders selling shares, particularly below current price, may be a negative signal. Despite this, the level of insider ownership indicates alignment with common shareholders. The absence of insider trading in the last quarter and recent transactions make us wary about Fluor.
1
Despite Fluor's lower than average ROE, the company demonstrates strong earnings growth and financial performance, likely due to high earnings retention and efficient management. Industry forecasts indicate that this earnings growth is expected to continue.
1
Pre-Market Stock Movers
Gapping up
$Intel (INTC.US)$ popped 2.5% after the chipmaker announced it would be operating its programmable chip unit as a standalone business complete. Intel plans to conduct an initial public offering for the unit within the next two to three years.
$Fluor (FLR.US)$ Shares climbed 2.4% following an upgrade to buy at UBS. The firm is bullish on the stock thanks to progress on legacy projects a...
Gapping up
$Intel (INTC.US)$ popped 2.5% after the chipmaker announced it would be operating its programmable chip unit as a standalone business complete. Intel plans to conduct an initial public offering for the unit within the next two to three years.
$Fluor (FLR.US)$ Shares climbed 2.4% following an upgrade to buy at UBS. The firm is bullish on the stock thanks to progress on legacy projects a...
22
1
Gapping up
In reaction to earnings/guidance:
• $Comtech Telecommunications (CMTL.US)$ +2.1%, $Micron Technology (MU.US)$+1.5%
Other news:
• $Amylyx Pharmaceuticals (AMLX.US)$ +9.3% (receives FDA approval for Relyvrio)
• $Ready Capital (RC.US)$ +4.9% (increases share buyback authorization by $25 mln)
• $Blue Apron (APRN.US)$ +2.5% (CFO to resign)
• $Fluor (FLR.US)$ +2.3% (US Dept of Energy extends Fluor-led Savannah River contract)
• $Immuneering (IMRX.US)$ +1.6% (re...
In reaction to earnings/guidance:
• $Comtech Telecommunications (CMTL.US)$ +2.1%, $Micron Technology (MU.US)$+1.5%
Other news:
• $Amylyx Pharmaceuticals (AMLX.US)$ +9.3% (receives FDA approval for Relyvrio)
• $Ready Capital (RC.US)$ +4.9% (increases share buyback authorization by $25 mln)
• $Blue Apron (APRN.US)$ +2.5% (CFO to resign)
• $Fluor (FLR.US)$ +2.3% (US Dept of Energy extends Fluor-led Savannah River contract)
• $Immuneering (IMRX.US)$ +1.6% (re...
10
Gainers:
• $Canoo (GOEV.US)$ +71.3% (receives purchase order of 4500 Canoo Electric Delivery Vehicles from Walmart)
• $Aldeyra Therapeutics (ALDX.US)$ +14.1% (achieved primary endpoints in dry eye disease chamber crossover clinical trial)
• $Westport Fuel (WPRT.US)$ +10.9% (awarded 38 mln program)
• $Greenwich LifeSciences (GLSI.US)$ +5.9% (FDA has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed...
• $Canoo (GOEV.US)$ +71.3% (receives purchase order of 4500 Canoo Electric Delivery Vehicles from Walmart)
• $Aldeyra Therapeutics (ALDX.US)$ +14.1% (achieved primary endpoints in dry eye disease chamber crossover clinical trial)
• $Westport Fuel (WPRT.US)$ +10.9% (awarded 38 mln program)
• $Greenwich LifeSciences (GLSI.US)$ +5.9% (FDA has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed...
14
Gainers:
• $La-Z-Boy (LZB.US)$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals (ENTA.US)$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer (PFE.US)$)
• $Ikena Oncology (IKNA.US)$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma (BBIO.US)$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech (KRYS.US)$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
• $La-Z-Boy (LZB.US)$ +9.3% (In reaction to earnings/guidance)
• $Enanta Pharmaceuticals (ENTA.US)$ +6.7% (ENTA files patent infringement lawsuit against $Pfizer (PFE.US)$)
• $Ikena Oncology (IKNA.US)$ +6.6% (granted Fast Track designation for IK-930)
• $BridgeBio Pharma (BBIO.US)$ +6.4% (Announces Early Positive Data for BBP-812)
• $Krystal Biotech (KRYS.US)$ +5% (submits Biologies License Application to FDA seeking approval of B-V...
8
1
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Gainers:
• $Signet Jewelers (SIG.US)$ +7.6% (In reaction to earnings/guidance)
• $Oxford Industries (OXM.US)$ +6.3% (In reaction to earnings/guidance)
• $BridgeBio Pharma (BBIO.US)$ +5%(to Present Phase 2b Data and Pivotal Phase 3 Study Design of Encaleret in Autosomal Dominant Hypocalcemia Type 1 (ADH1) at the Endocrine Society (ENDO) 2022 Annual Conference)
• $Greif (GEF.US)$ +4.6% (In reaction to earnings/guidance)
• $Olema Pharmaceuticals (OLMA.US)$ +4.3% (an...
• $Signet Jewelers (SIG.US)$ +7.6% (In reaction to earnings/guidance)
• $Oxford Industries (OXM.US)$ +6.3% (In reaction to earnings/guidance)
• $BridgeBio Pharma (BBIO.US)$ +5%(to Present Phase 2b Data and Pivotal Phase 3 Study Design of Encaleret in Autosomal Dominant Hypocalcemia Type 1 (ADH1) at the Endocrine Society (ENDO) 2022 Annual Conference)
• $Greif (GEF.US)$ +4.6% (In reaction to earnings/guidance)
• $Olema Pharmaceuticals (OLMA.US)$ +4.3% (an...
21
When allocating stocks to your portfolio you want them to increase in value obviously so you can make profit. You want good companies that provide value in a bull and bear market within sectors and industries that are trending up. You want good companies that are heavily invested by hedge funds and ETF’s. And you dont want too much volatility in the price action. You may also want defensive stocks that may provide a cushion to a falling market. Sometimes you will rotate investmen...
5
5
I’m forecasting a breakout with slight precipitation of cash
$Crude Oil Futures(OCT4) (CLmain.US)$ $Exxon Mobil (XOM.US)$ $SPDR S&P Oil & Gas Exploration & Production ETF (XOP.US)$ $Valero Energy (VLO.US)$ $Schlumberger (SLB.US)$ $Fluor (FLR.US)$ $US Well Services (USWS.US)$ $Imperial Petroleum (IMPP.US)$ $ConocoPhillips (COP.US)$ $Chevron (CVX.US)$ $BP PLC (BP.US)$ $Marathon Oil (MRO.US)$ $Marathon Petroleum (MPC.US)$ $Devon Energy (DVN.US)$
$Crude Oil Futures(OCT4) (CLmain.US)$ $Exxon Mobil (XOM.US)$ $SPDR S&P Oil & Gas Exploration & Production ETF (XOP.US)$ $Valero Energy (VLO.US)$ $Schlumberger (SLB.US)$ $Fluor (FLR.US)$ $US Well Services (USWS.US)$ $Imperial Petroleum (IMPP.US)$ $ConocoPhillips (COP.US)$ $Chevron (CVX.US)$ $BP PLC (BP.US)$ $Marathon Oil (MRO.US)$ $Marathon Petroleum (MPC.US)$ $Devon Energy (DVN.US)$
9
77
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
White_Shadow :
Mark Paluzzi White_Shadow : fake news he got cut falling down!
david Roberts7 : you go mr. president
70729743 :
sick4cash : He was almost assassinated By a conservative, what are you talking about?His own people
View more comments...